Complementary Utility of Dopamine Transporter and Tau PET Imaging in the Diagnosis of Progressive Supranuclear Palsy: A Case Report

Chenhao Jia, Meiqi Wu, Tzu Chen Yen, Yanfeng Li, Ruixue Cui*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

2 Scopus citations

Abstract

A 50-year-old woman developed gait disturbances, tendency to fall backwards, bradykinesia, and memory loss over the previous 6 months. Brain 18F-FDG PET/CT was unable to distinguish among APSs (atypical parkinsonian syndromes); PET investigations of dopamine transporter (DAT) function (11C-CFT) and tau pathology (18F-APN-1607) were performed. 11C-CFT PET revealed severe loss of striatal DAT function, whereas significant tau accumulation was observed in the brainstem, basal ganglia, and globus pallidus on 18F-APN-1607 PET. Such finding suggested diagnosis of PSP (progressive supranuclear palsy). This case highlights the value of DAT and tau PET imaging in diagnosis of PSP and differential diagnosis ofAPSs.

Original languageEnglish
Pages (from-to)336-338
Number of pages3
JournalClinical Nuclear Medicine
Volume47
Issue number4
DOIs
StatePublished - 01 04 2022
Externally publishedYes

Bibliographical note

Publisher Copyright:
© Wolters Kluwer Health, Inc. All rights reserved.

Keywords

  • atypical parkinsonian syndromes
  • dopamine transporter function
  • positron emission tomography
  • progressive supranuclear palsy
  • tau imaging

Fingerprint

Dive into the research topics of 'Complementary Utility of Dopamine Transporter and Tau PET Imaging in the Diagnosis of Progressive Supranuclear Palsy: A Case Report'. Together they form a unique fingerprint.

Cite this